ArticleFrontiers in medicine2019

Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease.

Mauro Mastronardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.